comparemela.com

Latest Breaking News On - Left atrial appendage occlusion registry - Page 1 : comparemela.com

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation

United statesIan meredithAmerican college of cardiology foundationBoston scientific corporationDrug administrationBoston scientificNational cardiovascular data registryAtrial appendage closureLeft atrial appendage occlusion registryAmerican collegeCardiology foundationRecent clinical data supportingAmplatzer amulet

FDA approves expanded label for Boston Scientific Watchman FLX

Boston Scientific announced today that the FDA approved expanded labeling for its Watchman FLX LAAC device for stroke prevention.

United statesIan meredithAmerican college of cardiology foundationBoston scientificNational cardiovascular data registryMassachusetts based boston scientificLeft atrial appendage occlusion registryAmerican collegeCardiology foundationAmplatzer amulet

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation.

United statesIan meredithExchange commissionAmerican college of cardiology foundationSecurities exchangeBoston scientificNational cardiovascular data registryLeft atrial appendage closureLeft atrial appendage occlusion registryAmerican collegeCardiology foundationRecent clinical data supportingSecurities actSecurities exchange actRisk factorsAnnual report

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use.

United statesLauren tenglerIan meredithAngela mineoBoston scientific corporationDrug administrationBoston scientificNational cardiovascular data registryExchange commissionAmerican college of cardiology foundationPrnewswire boston scientific corporationSecurities exchangeScientific corporationLeft atrial appendage closureLeft atrial appendage occlusion registryAmerican college

Boston Scientific Gets FDA Approval For Expanded Labeling Of WATCHMAN FLX LAAC Device

WASHINGTON (dpa-AFX) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday that it has received U.S. Food and Drug Administration approval for expanded labeling of WATCHMAN

United statesBoston scientific corpDrug administrationMore such health newsBoston scientificAtrial appendage closureLeft atrial appendage occlusion registry

vimarsana © 2020. All Rights Reserved.